Ingevity Corporation (NGVT) is a publicly traded Basic Materials sector company. As of May 21, 2026, NGVT trades at $66.09 with a market cap of $2.31B and a P/E ratio of -19.20. NGVT moved +1.63% today. Year to date, NGVT is +8.59%; over the trailing twelve months it is +55.25%. Its 52-week range spans $28.49 to $79.29. Analyst consensus is buy with an average price target of $80.00. Rallies surfaces NGVT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Ingevity Reports 8% Sales Drop, 10% EBITDA Growth and $4.08–$5.20 EPS Guidance: In 2025, Ingevity’s sales fell 8% to $1.3 billion, while EBITDA rose 10% to $398 million and EPS jumped 30% to $4.55, following the Jan. 1 sale of its North Charleston CTO refinery and Industrial Specialties line. For 2026: EPS $4.08–$5.20, sales $1.1–$1.2 billion, free cash flow $225–$250 million; $300 million buyback through 2027.
| Metric | Value |
|---|---|
| Price | $66.09 |
| Market Cap | $2.31B |
| P/E Ratio | -19.20 |
| EPS | $-3.46 |
| Dividend Yield | 0.00% |
| 52-Week High | $79.29 |
| 52-Week Low | $28.49 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $1.21B |
| Net Income | $-127.80M |
| Gross Margin | 39.30% |
2 analysts cover NGVT: 0 strong buy, 1 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $80.00.